Generate a tailored SOP for Dr. Alexandra Rojek. Improve your application with a focused, well-structured draft.
Alexandra Rojek, MD, is a hematologist/oncologist at the University of Chicago focusing on the care of adults with lymphoma, particularly using chimeric antigen receptor (CAR) T-cell therapy as a treatment for lymphoma patients. She has expertise in treating non-Hodgkin lymphomas, Hodgkin lymphoma, T-cell lymphomas, and the role of stem cell transplantation in lymphoma treatment, alongside CAR T-cell therapy. Dr. Rojek’s laboratory research is centered on identifying the immunological mechanisms that underlie the success of cellular therapies, and she works on developing strategies to leverage these mechanisms to improve the efficacy of cellular therapies for patients. Her research aims to translate findings from early-phase trials that utilize these cellular therapies for patients with lymphoma malignancies.
University of Chicago • Chicago, IL
Teaching and conducting research in hematology and oncology.
Department of Philosophy